Found: 19
Select item for more details and to access through your institution.
Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae063
- By:
- Publication type:
- Article
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 2, p. 230, doi. 10.1093/rheumatology/kev297
- By:
- Publication type:
- Article
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data.
- Published in:
- Rheumatology, 2022, v. 61, n. 10, p. 3952, doi. 10.1093/rheumatology/keac068
- By:
- Publication type:
- Article
occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3647, doi. 10.1093/rheumatology/keab946
- By:
- Publication type:
- Article
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3596, doi. 10.1093/rheumatology/keab933
- By:
- Publication type:
- Article
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2019, v. 58, n. 12, p. 2170, doi. 10.1093/rheumatology/kez191
- By:
- Publication type:
- Article
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295838
- By:
- Publication type:
- Article
Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy.
- Published in:
- Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2936962
- By:
- Publication type:
- Article
Corrigendum to "Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy".
- Published in:
- Journal of Diabetes Research, 2021, p. 1, doi. 10.1155/2021/9827150
- By:
- Publication type:
- Article
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-0951-z
- By:
- Publication type:
- Article
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.
- Published in:
- Lupus, 2024, v. 33, n. 6, p. 615, doi. 10.1177/09612033241242692
- By:
- Publication type:
- Article
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis.
- Published in:
- Journal of Rheumatology, 2021, v. 48, n. 10, p. 1512, doi. 10.3899/jrheum.201467
- By:
- Publication type:
- Article
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intracardiac Thrombi in Morbus Adamantiades–Behçet in Two Swedish Patients.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1813, doi. 10.3390/jcm9061813
- By:
- Publication type:
- Article
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 5, p. 1687, doi. 10.1007/s10067-020-05420-w
- By:
- Publication type:
- Article
Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 3, p. 957, doi. 10.1007/s10067-019-04882-x
- By:
- Publication type:
- Article
Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2020, p. 1, doi. 10.1177/1759720X20976975
- By:
- Publication type:
- Article
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1151-6
- By:
- Publication type:
- Article